텔콘RF제약

200230KOSDAQSector: Pharma & Biotech

₩2,010▼ 3.13%Market cap ₩14.4BAs of Jul 21, 2026 close · updated once daily

Grade B58.4 ptsTop 37% of 2,523 stocks

Financial strength

47.9

Growth momentum

83.7

Price attractiveness

52.3

As of Jul 21, 2026 close · This grade is not a buy/sell recommendation — it is information mechanically scored from public data using a fixed formula.

Financial strength

47.9

How much debt does it carry relative to equity?

Debt-to-equity ratio

44.0%

✓ Above median · Top 41.3% in sector

Sector median 51.5%

Can it cover what's due within a year?

Current ratio

124.8%

✗ Below median · Top 66.1% in sector

Sector median 191.3%

How much of revenue becomes profit?

Operating margin

1.7%

✓ Above median · Top 43.4% in sector

Sector median -2.3%

How much did it earn on its own capital?

ROE (return on equity)

-10.6%

✗ Below median · Top 57.5% in sector

Sector median -4.5%

Source filing: annual report (consolidated) — view original ↗

Growth momentum

83.7

How much did revenue grow in a year?

Revenue growth (YoY)

14.0%

✓ Above median · Top 31.7% in sector

Sector median 6.4%

Has it grown steadily over three years?

Revenue 3-year CAGR

15.8%

✓ Above median · Top 18.4% in sector

Sector median 4.9%

Did core profits grow in a year?

Operating income change (YoY)

1118.6%

✓ Above median · Top 1.6% in sector

Sector median 3.6%

Are core profits higher than three years ago?

Operating income change (3Y)

117.7%

✓ Above median · Top 13.7% in sector

Sector median 3.5%

Source filing: annual report (consolidated) — view original ↗

Price attractiveness

52.3

Is the price expensive relative to earnings?

P/E (price-to-earnings)

Loss-making (P/E not computable)

✗ Below median · Top 95.3% in sector

Sector median P/E of profitable peers 14.4x · 57% loss-making

Is the price expensive relative to book value?

P/B (price-to-book)

0.13x

✓ Above median · Top 0.2% in sector

Sector median 1.39x

Valuation uses the Jul 21, 2026 close and market cap

Grade distribution of 248 stocks in Pharma & Biotech

S1A52B66C51D61F15